chr20-46177989-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_021248.3(CDH22):c.1872C>T(p.Pro624=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00299 in 1,614,046 control chromosomes in the GnomAD database, including 113 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0040 ( 9 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 104 hom. )
Consequence
CDH22
NM_021248.3 synonymous
NM_021248.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -6.08
Genes affected
CDH22 (HGNC:13251): (cadherin 22) This gene is a member of the cadherin superfamily. The gene product is composed of five cadherin repeat domains and a cytoplasmic tail similar to the highly conserved cytoplasmic region of classical cadherins. Expressed predominantly in the brain, this putative calcium-dependent cell adhesion protein may play an important role in morphogenesis and tissue formation in neural and non-neural cells during development and maintenance of the brain and neuroendocrine organs. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 20-46177989-G-A is Benign according to our data. Variant chr20-46177989-G-A is described in ClinVar as [Benign]. Clinvar id is 773919.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.08 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0583 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDH22 | NM_021248.3 | c.1872C>T | p.Pro624= | synonymous_variant | 11/12 | ENST00000537909.4 | |
CDH22 | XM_011528994.3 | c.1872C>T | p.Pro624= | synonymous_variant | 11/12 | ||
CDH22 | XM_047440373.1 | c.1632C>T | p.Pro544= | synonymous_variant | 9/10 | ||
CDH22 | XM_024451966.2 | c.1509C>T | p.Pro503= | synonymous_variant | 11/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDH22 | ENST00000537909.4 | c.1872C>T | p.Pro624= | synonymous_variant | 11/12 | 2 | NM_021248.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00403 AC: 614AN: 152186Hom.: 9 Cov.: 32
GnomAD3 genomes
AF:
AC:
614
AN:
152186
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00958 AC: 2402AN: 250700Hom.: 58 AF XY: 0.00803 AC XY: 1088AN XY: 135558
GnomAD3 exomes
AF:
AC:
2402
AN:
250700
Hom.:
AF XY:
AC XY:
1088
AN XY:
135558
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00289 AC: 4219AN: 1461742Hom.: 104 Cov.: 32 AF XY: 0.00264 AC XY: 1920AN XY: 727168
GnomAD4 exome
AF:
AC:
4219
AN:
1461742
Hom.:
Cov.:
32
AF XY:
AC XY:
1920
AN XY:
727168
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00401 AC: 611AN: 152304Hom.: 9 Cov.: 32 AF XY: 0.00414 AC XY: 308AN XY: 74478
GnomAD4 genome
AF:
AC:
611
AN:
152304
Hom.:
Cov.:
32
AF XY:
AC XY:
308
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
74
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 20, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at